153 related articles for article (PubMed ID: 2525013)
1. Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs.
Mannucci PM; Zanetti AR; Gringeri A; Tanzi E; Morfini M; Messori A; Tirindelli MC; de Biasi R; Ciavarella N; Colombo M
Arch Intern Med; 1989 Jun; 149(6):1333-7. PubMed ID: 2525013
[TBL] [Abstract][Full Text] [Related]
2. Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients.
Santagostino E; Gringeri A; Rocino A; Zanetti A; de Biasi R; Mannucci PM
Thromb Haemost; 1994 Oct; 72(4):508-10. PubMed ID: 7878624
[TBL] [Abstract][Full Text] [Related]
3. Loss of hepatitis B antibody in human immunodeficiency virus-positive hemophilia patients.
Drake JH; Parmley RT; Britton HA
Pediatr Infect Dis J; 1987 Nov; 6(11):1051-4. PubMed ID: 2962061
[TBL] [Abstract][Full Text] [Related]
4. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
Ristola MA; Vuola JM; Valle M; von Reyn CF
Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of hepatitis B vaccine in a simplified immunization programme.
Coursaget P; Yvonnet B; Sarr M; Vincelot P; Tortey E; Mboup S; Chiron JP; Diop-Mar I
Bull World Health Organ; 1986; 64(6):867-71. PubMed ID: 2951032
[TBL] [Abstract][Full Text] [Related]
9. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children.
Yuen MF; Lim WL; Cheng CC; Lam SK; Lai CL
Hepatology; 1999 Mar; 29(3):924-7. PubMed ID: 10051499
[TBL] [Abstract][Full Text] [Related]
10. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.
Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY
Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627
[TBL] [Abstract][Full Text] [Related]
11. [The immunogenicity of the hepatitis B vaccine in drug addicts with human immunodeficiency virus infection].
Menicagli V; Barbanera M; Menicagli S
Recenti Prog Med; 1991 Feb; 82(2):69-71. PubMed ID: 2034870
[TBL] [Abstract][Full Text] [Related]
12. A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates.
Ding L; Zhang M; Wang Y; Zhou S; Kong W; Smego RA
Clin Infect Dis; 1993 Sep; 17(3):475-9. PubMed ID: 8218692
[TBL] [Abstract][Full Text] [Related]
13. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
[TBL] [Abstract][Full Text] [Related]
14. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
15. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccine: prospects for duration of immunity.
Krugman S; Davidson M
Yale J Biol Med; 1987; 60(4):333-9. PubMed ID: 3660859
[TBL] [Abstract][Full Text] [Related]
17. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
18. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
[TBL] [Abstract][Full Text] [Related]
19. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
Xia G; Jia Z; Yan T; Li R; Liu H; Xu Z; Cao H; Liu C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
[TBL] [Abstract][Full Text] [Related]
20. A review of the long-term protection after hepatitis A and B vaccination.
Van Damme P; Van Herck K
Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
